World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
77
Citations
19235
World Ranking
1666
National Ranking
985

David Mischoulon publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where David Mischoulon sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 360 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

David Mischoulon D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where David Mischoulon sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 77 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

David Mischoulon is affiliated with Harvard University in the United States. Their research primarily focuses on Medicine and Psychology, with significant contributions in subfields such as Clinical Psychology, Psychiatry and Mental Health, Biological Psychiatry, Experimental and Cognitive Psychology, and Physiology.

The main topics covered in their work include Tryptophan and brain disorders, Treatment of Major Depression, Stress Responses and Cortisol, Diet and metabolism studies, Mental Health Research Topics, Mental Health Treatment and Access, and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes.

Among their recent publications are:

  • Diet and depression: exploring the biological mechanisms of action (2020, Molecular Psychiatry)
  • Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce (2022, The World Journal of Biological Psychiatry)
  • Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors (2020, Frontiers in Psychiatry)
  • Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores (2020, JAMA)
  • Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores (2021, JAMA)

Frequent co-authors in their collaborative work include:

  • Maurizio Fava
  • Olivia I. Okereke
  • Hong Jin Jeon
  • Maren Nyer
  • Charles F. Reynolds

Mischoulon's publications are often found in notable journals such as:

  • Journal of Affective Disorders
  • Frontiers in Psychiatry
  • The Journal of Clinical Psychiatry
  • American Journal of Geriatric Psychiatry
  • Alzheimer's & Dementia

Best Publications

  • Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry

    Marlene P. Freeman;Joseph R. Hibbeln;Katherine L. Wisner;John M. Davis;John M. Davis

  • Nutritional medicine as mainstream in psychiatry.

    Jerome Sarris;Jerome Sarris;Alan C Logan;Tasnime N Akbaraly;Tasnime N Akbaraly;G. Paul Amminger

  • Diet and depression: exploring the biological mechanisms of action

    Wolfgang Marx;Melissa Lane;Meghan Hockey;Hajara Aslam

  • Quality of life assessments in major depressive disorder: a review of the literature.

    George I. Papakostas;Timothy Petersen;Yasmin Mahal;David Mischoulon

  • Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

    Jerome Sarris;Jenifer Murphy;David Mischoulon;George I. Papakostas

  • Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence

    David Mischoulon;Maurizio Fava

  • S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial

    George I. Papakostas;David Mischoulon;Irene Shyu;Jonathan E. Alpert

  • Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression

    Jerome Sarris;David Mischoulon;Isaac Schweitzer

  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

    George I. Papakostas;Richard C. Shelton;John M. Zajecka;Bijan Etemad

  • Relationship between sleep disturbance and depression, anxiety, and functioning in college students.

    Maren Nyer;Amy Farabaugh;B A Kiki Fehling;David Soskin

  • Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors.

    Basabi Rana;D. Mischoulon;Yuhong Xie;N. L. R. Bucher

  • Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

    Mark Hyman Rapaport;Andrew A Nierenberg;Pamela J. Schettler;Becky Kinkead

  • Nutrition and depression: focus on folate.

    Jonathan E Alpert;David Mischoulon;Andrew A Nierenberg;Maurizio Fava

  • A Double-blind, Randomized Trial of St John's Wort, Fluoxetine, and Placebo in Major Depressive Disorder

    Maurizio Fava;Jonathan Alpert;Andrew A. Nierenberg;David Mischoulon

  • Frontal EEG predictors of treatment outcome in major depressive disorder.

    Dan V. Iosifescu;Scott Greenwald;Philip Devlin;David Mischoulon

  • Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.

    Roy H. Perlis;David Mischoulon;Jordan W. Smoller;Yu-Jui Yvonne Wan

  • THE DNA BINDING ACTIVITY OF C/EBP TRANSCRIPTION FACTORS IS REGULATED IN THE G1 PHASE OF THE HEPATOCYTE CELL CYCLE

    Basabi Rana;Yuhong Xie;David Mischoulon;Nancy L.R. Bucher

  • Folate in depression: efficacy, safety, differences in formulations, and clinical issues

    M. Fava;D. Mischoulon

  • Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression.

    Marasha de Jong;Marasha de Jong;Sara W. Lazar;Kiran Hug;Kiran Hug;Wolf E. Mehling

  • International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.

    Ta Wei Guu;David Mischoulon;Jerome Sarris;Jerome Sarris;Joseph Hibbeln

  • Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBP alpha) gene expression during hepatocyte proliferation in the regenerating liver and in culture.

    D. Mischoulon;B. Rana;N. L. R. Bucher;S. R. Farmer

  • Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.

    George I. Papakostas;Dost Öngür;Dan V. Iosifescu;David Mischoulon

Frequent Co-Authors

Maurizio Fava
Maurizio Fava Harvard University
George I. Papakostas
George I. Papakostas Harvard University
Jonathan E. Alpert
Jonathan E. Alpert Harvard University
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Albert Yeung
Albert Yeung Harvard University
Lee Baer
Lee Baer Harvard University
Cristina Cusin
Cristina Cusin Harvard University
Paola Pedrelli
Paola Pedrelli Massachusetts General Hospital
JoAnn E. Manson
JoAnn E. Manson Harvard Medical School
Jerrold F. Rosenbaum
Jerrold F. Rosenbaum Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a Psychology degree in the USA opens doors to many related online degrees and career pathways, especially in fields like social work. Many students consider social work as a complementary or alternative career, given its focus on human behavior, community well-being, and direct impact.

Seeking affordability is key when selecting the right program. For those researching regional options, you can find most affordable social work degree programs in Tallahassee and cheapest social work programs in Utah, both offering budget-friendly options for prospective students.

Looking nationally, many schools offer online degrees at varying price points. For an overview, check out the cheapest social work degrees in USA list to compare programs across the country. If you are targeting the East Coast, you may also be interested in the cheapest social work degrees in Virginia.

Whether you pursue psychology or social work online, both fields prepare graduates for meaningful roles in mental health, counseling, and community support. Choosing an affordable program ensures you can kick-start your career without unnecessary financial strain.

Best Scientists Citing David Mischoulon

Trending Scientists

Recently Published Articles